2025 UPDATES: Please bring all new insurance cards to your next appointment and verify your address and phone number when you check in at the front desk. 

Clinical Research & Trials

uso 24063

A Phase 2 Multiple-Dose, Multiple-Arm, Parallel Assignment Study to evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer (XmAb20717-04)

 

Disease Types: Genitourinary Cancer Research

Available at: